Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts

  Hepatitis C

  Free Subscription


1 Am J Gastroenterol
1 Gastroenterology
1 J Gastroenterol
1 J Gen Virol
1 J Hepatol
1 J Infect Dis
1 J Virol
1 Lancet Gastroenterol Hepatol
3 PLoS One
1 Transplant Proc
1 Virology

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Am J Gastroenterol

  1. KWO PY, Shiffman ML, Bernstein DE
    The Cochrane Review Conclusion for Hepatitis C DAA Therapies is Wrong.
    Am J Gastroenterol. 2017 Nov 14. doi: 10.1038/ajg.2017.
    PubMed     Text format    


  2. DIETZ J, Susser S, Vermehren J, Peiffer KH, et al
    Patterns of Resistance-associated Substitutions in Patients With Chronic HCV Infection Following Treatment with Direct-acting Antivirals.
    Gastroenterology. 2017 Nov 13. pii: S0016-5085(17)36353.
    PubMed     Text format     Abstract available

    J Gastroenterol

  3. KUMADA H, Watanabe T, Suzuki F, Ikeda K, et al
    Correction to: Efficacy and safety of glecaprevir/pibrentasvir in HCV-infected Japanese patients with prior DAA experience, severe renal impairment, or genotype 3 infection.
    J Gastroenterol. 2017 Nov 13. doi: 10.1007/s00535-017-1409.
    PubMed     Text format     Abstract available

    J Gen Virol

  4. GOONAWARDANE N, Ross-Thriepland D, Harris M
    Regulation of hepatitis C virus replication via threonine phosphorylation of the NS5A protein.
    J Gen Virol. 2017 Nov 15. doi: 10.1099/jgv.0.000975.
    PubMed     Text format     Abstract available

    J Hepatol

  5. BUGGISCH P, Vermehren J, Mauss S, Gunther R, et al
    Real-world effectiveness of 8 weeks treatment with ledipasvir/sofosbuvir in chronic hepatitis C.
    J Hepatol. 2017 Nov 10. pii: S0168-8278(17)32431.
    PubMed     Text format     Abstract available

    J Infect Dis

  6. STEBA GS, Koekkoek SM, Vanhommerig JW, Brinkman K, et al
    DC-SIGN Polymorphisms Associated with Risk of Hepatitis C Virus Infection Among Men who Have Sex with Men but not Among Injecting Drug Users.
    J Infect Dis. 2017 Nov 13. doi: 10.1093.
    PubMed     Text format     Abstract available

    J Virol

  7. DIXIT U, Pandey AK, Liu Z, Kumar S, et al
    Correction for Dixit et al., "FUSE Binding Protein 1 Facilitates Persistent Hepatitis C Virus Replication in Hepatoma Cells by Regulating Tumor Suppressor p53".
    J Virol. 2017;91.
    PubMed     Text format    

    Lancet Gastroenterol Hepatol

  8. SONDERUP MW, Afihene M, Ally R, Apica B, et al
    Hepatitis C in sub-Saharan Africa: the current status and recommendations for achieving elimination by 2030.
    Lancet Gastroenterol Hepatol. 2017;2:910-919.
    PubMed     Text format     Abstract available

    PLoS One

  9. SHIMIZU JF, Pereira CM, Bittar C, Batista MN, et al
    Multiple effects of toxins isolated from Crotalus durissus terrificus on the hepatitis C virus life cycle.
    PLoS One. 2017;12:e0187857.
    PubMed     Text format     Abstract available

  10. STROFFOLINI T, Sagnelli E, Andriulli A, Colloredo G, et al
    Sex difference in the interaction of alcohol intake, hepatitis B virus, and hepatitis C virus on the risk of cirrhosis.
    PLoS One. 2017;12:e0185710.
    PubMed     Text format     Abstract available

  11. GARRIGA C, Manzanares-Laya S, Garcia de Olalla P, Gorrindo P, et al
    Evolution of acute hepatitis C virus infection in a large European city: Trends and new patterns.
    PLoS One. 2017;12:e0187893.
    PubMed     Text format     Abstract available

    Transplant Proc

  12. TOWNSEND SA, Monga MA, Nightingale P, Mutimer D, et al
    Hepatitis C Virus Recurrence Occurs Earlier in Patients Receiving Donation After Circulatory Death Liver Transplant Grafts Compared With Those Receiving Donation After Brainstem Death Grafts.
    Transplant Proc. 2017;49:2129-2134.
    PubMed     Text format     Abstract available


  13. MESALAM AA, Desombere I, Farhoudi A, Van Houtte F, et al
    Development and characterization of a human monoclonal antibody targeting the N-terminal region of hepatitis C virus envelope glycoprotein E1.
    Virology. 2017;514:30-41.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis C is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.